Hyperphosphatemia in end stage renal disease patients undergoing maintenance hemodialysis at a tertiary care hospital in Ras Al Khaimah, UAE
Syed Arman Rabbani, Sathvik B S, Padma G M Rao, Martin Thomas and A B El Essawy
RAK Medical and Health Sciences University, UAE
Ibrahim bin Hamad Obaidallah Hospital, UAE
: J Pharm Drug Deliv
Abstract
The objective of the study was to assess the prevalence of hyperphosphatemia in end stage renal disease patients (ESRD) undergoing maintenance hemodialysis at a tertiary care hospital in Ras Al Khaimah, UAE. The study also aimed to describe the characteristics of the ESRD patients with hyperphosphatemia. The study was a prospective, observational study including all the patients undergoing hemodialysis at the nephrology unit of the hospital. Patients who were on hemodialysis for less than six months, with less than thrice weekly hemodialysis and with acute kidney injury were excluded from the study. Patients’ characteristics were compared according to phosphatemia level, between patients with or without hyperphosphatemia Of the 80 patients included (mean age, 61.1 ± 9.4 years), 73.8% had hyperphosphatemia, defined by a mean serum phosphate > 1.45 mmol/L. Patients with hyperphosphatemia were younger and had a higher BMI than those with normal phosphate levels, and more often women. They were more likely to have hypertensive and diabetic nephropathy, and had less co-morbidity. The study showed that ESRD patients with hyperphosphatemia differ from those with normal phosphate levels.
Biography
Email: arman@rakmhsu.ac.ae
